Estrogenic activity of bisphenol A and 2,2-bis(p-hydroxyphenyl)-1,1,1-trichloroethane (HPTE) demonstrated in mouse uterine gene profiles.
BACKGROUND
Interest and concern regarding potentially estrogenic substances have resulted in development of model systems to evaluate mechanisms of such chemicals. Microarray studies have indicated that estradiol (E2)-stimulated uterine responses can be divided into early and late phases. Comparison of E2 uterine transcript profiles and those of other estrogenic chemicals of interest in vivo indicates mechanisms and activities of test compounds.


OBJECTIVE
We compared transcript responses and mechanisms of response using mouse reproductive tracts after treatment with E2, estriol (E3), bisphenol A (BPA), and 2,2-bis(p-hydroxyphenyl)-1,1,1-trichloroethane (HPTE).


METHODS
Uterine RNA from ovariectomized wild-type mice, estrogen receptor α (ERα) knockout (αERKO) mice, and mice expressing a DNA-binding-deficient ERα (KIKO) treated with E2, E3, BPA, or HPTE for 2 or 24 hr was analyzed by microarray. Resulting regulated transcripts were compared by hierarchical clustering and correlation analysis, and response patterns were verified by reverse-transcription real-time polymerase chain reaction (RT-PCR).


RESULTS
Both xenoestrogens, BPA and HPTE, showed profiles highly correlated to that of E2 in the early response phase (2 hr), but the correlation diminished in the later response phase (24 hr), similar to the known weak estrogen E3. Both xenoestrogens also mimicked E2 in samples from KIKO mice, indicating that they are able to utilize the indirect tethering mode of ERα signaling. No response was detected in ERα-null uteri, indicating that ERα mediates the responses.


CONCLUSIONS
Our study forms a basis on which patterns of response and molecular mechanisms of potentially estrogenic chemicals can be assessed.
Hewitt
Sylvia C
SC
Receptor Biology Section, Laboratory of Reproductive and Developmental Toxicology, National Institute of Environmental Health Sciences, National Institutes of Health, Department of Health and Human Services, Research Triangle Park, North Carolina 27709, USA. curtiss@niehs.nih.gov
Korach
Kenneth S
KS
D000818:Animals; D001559:Benzhydryl Compounds; D004964:Estriol / Q000633:toxicity; D047628:Estrogen Receptor alpha / Q000235:genetics / Q000378:metabolism; D004967:Estrogens / Q000633:toxicity*; D005260:Female; D015870:Gene Expression / Q000187:drug effects; D020869:Gene Expression Profiling; D019394:Ki-67 Antigen / Q000235:genetics / Q000378:metabolism; D008297:Male; D051379:Mice; D018345:Mice, Knockout; D010636:Phenols / Q000633:toxicity*; D020133:Reverse Transcriptase Polymerase Chain Reaction; D014599:Uterus / Q000187:drug effects* / Q000378:metabolism; D000098826:Bisphenol A Compounds
D001559:Benzhydryl Compounds; D004964:Estriol; D047628:Estrogen Receptor alpha; D004967:Estrogens; D019394:Ki-67 Antigen; D010636:Phenols; C404910:2,2-bis(4-hydroxyphenyl)-1,1,1-trichloroethane; C006780:bisphenol A; D000098826:Bisphenol A Compounds
Toxicology. 2005 Oct 1;213(3):177-93
15996808
Mol Endocrinol. 1995 Nov;9(11):1441-54
8584021
J Biol Chem. 2006 Aug 11;281(32):22429-33
16793760
Endocr Rev. 2009 Feb;30(1):75-95
19074586
Mol Endocrinol. 2004 Aug;18(8):1859-75
15031323
Endocrinology. 1976 Jan;98(1):220-7
174891
Toxicol Sci. 2002 Aug;68(2):473-8
12151644
FASEB J. 2010 Dec;24(12):4660-7
20667977
J Steroid Biochem Mol Biol. 2004 Jan;88(1):53-9
15026083
Endocr Rev. 2009 Jun;30(4):293-342
19502515
Mol Cell Endocrinol. 2000 Apr 25;162(1-2):211-20
10854714
Endocrinology. 2006 May;147(5):2203-14
16469803
Mol Endocrinol. 2005 Apr;19(4):833-42
15695368
Mol Endocrinol. 2009 Dec;23(12):2111-6
19812388
Endocrinology. 2000 Sep;141(9):3430-9
10965916
J Mol Endocrinol. 2008 Nov;41(5):263-75
18772268
Chem Res Toxicol. 2008 Nov;21(11):2195-206
18921983
Proc Natl Acad Sci U S A. 1993 Dec 1;90(23):11162-6
8248223
Med Hypotheses. 2009 Jun;72(6):652-6
19155145
Environ Health Perspect. 2009 Mar;117(3):309-15
19337501
Reprod Toxicol. 2007 Aug-Sep;24(2):139-77
17825522
J Steroid Biochem Mol Biol. 2008 May;110(1-2):104-15
18400491
Mol Endocrinol. 2003 Oct;17(10):2070-83
12893882
Reprod Toxicol. 2007 Aug-Sep;24(2):131-8
17768031
Int J Occup Environ Health. 2009 Jan-Mar;15(1):43-78
19267126
Bioinformatics. 2006 May 1;22(9):1111-21
16522673
Toxicol Sci. 2004 Dec;82(2):458-67
15456929
J Biol Chem. 2001 Apr 27;276(17):13615-21
11278408
Mol Endocrinol. 2005 Mar;19(3):657-68
15528273
Toxicol Appl Pharmacol. 2009 Apr 1;236(1):85-96
19371625
Reprod Fertil Dev. 2001;13(4):307-15
11800169
Endocrinology. 1999 Dec;140(12):5746-53
10579340
J Biol Chem. 2010 Jan 22;285(4):2676-85
19920132
Toxicol Sci. 2006 Sep;93(1):180-8
16760418
Reprod Toxicol. 2008 Apr;25(3):316-26
18434086
J Steroid Biochem. 1984 Apr;20(4B):1033-7
6727348
Mol Endocrinol. 2008 May;22(5):1125-40
18202148
J Biol Chem. 2006 Sep 8;281(36):26683-92
16847062
Environ Health Perspect. 2001 Jan;109(1):55-60
11171525
Reprod Toxicol. 2001 May-Jun;15(3):245-52
11390168
J Steroid Biochem. 1984 Apr;20(4B):1005-13
6202959
Mol Pharmacol. 2000 Oct;58(4):852-8
10999957
Exp Cell Res. 2008 Apr 1;314(6):1217-28
18281035
Toxicol Sci. 2001 Sep;63(1):47-56
11509743